Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review
FL Ruberg, M Grogan, M Hanna, JW Kelly… - Journal of the American …, 2019 - jacc.org
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an under-recognized cause of heart
failure (HF) in older adults, resulting from myocardial deposition of misfolded transthyretin …
failure (HF) in older adults, resulting from myocardial deposition of misfolded transthyretin …
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …
S Dorbala, Y Ando, S Bokhari… - Circulation …, 2021 - Am Heart Assoc
Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
Background—Cardiac transthyretin (ATTR) amyloidosis is a progressive and fatal
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
[HTML][HTML] Cardiac T1 map** and extracellular volume (ECV) in clinical practice: a comprehensive review
Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …
AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy
RH Falk, KM Alexander, R Liao, S Dorbala - Journal of the American …, 2016 - jacc.org
The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis
Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis in
everyday clinical practice, but the diagnosis continues to be made in patients with late-stage …
everyday clinical practice, but the diagnosis continues to be made in patients with late-stage …
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
Background—The prognosis and treatment of the 2 main types of cardiac amyloidosis,
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …
Magnetic resonance in transthyretin cardiac amyloidosis
A Martinez-Naharro, TA Treibel, A Abdel-Gadir… - Journal of the American …, 2017 - jacc.org
Background: Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement …
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement …
Diagnosis, prognosis, and therapy of transthyretin amyloidosis
MA Gertz, MD Benson, PJ Dyck, M Grogan… - Journal of the American …, 2015 - jacc.org
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …
Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis
A Castano, M Haq, DL Narotsky, J Goldsmith… - JAMA …, 2016 - jamanetwork.com
Importance Transthyretin cardiac amyloidosis (also known as ATTR cardiac amyloidosis) is
an increasingly recognized cause of heart failure with preserved ejection fraction. In single …
an increasingly recognized cause of heart failure with preserved ejection fraction. In single …